Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T22:15:52.240Z.
Calculation as of: 2026-10-06T22:15:52.240Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c64da899843448fde498cf5e629ee28b7cf55c7878198a0aebccb75d14602d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-05-16.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aspire Biopharma Holdings, Inc.
Market Cap
$1.01M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$946332.00
Price/OCF Ratio
N/A
TTM Avg
13238.57
3Y Avg
13238.57
5Y Avg
13238.57
Market Cap
$1.13M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$868077.00
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838843.00
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.01M | N/A | N/A | N/A | N/A |
| Sunshine Biopharma, Inc. (SBFM)vs › | $946332.00 | N/A | 13238.57 | 13238.57 | 13238.57 |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A | N/A | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.12M | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.13M | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | 2.88 | 2.62 | 2.62 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A | 0.30 | 0.38 | 0.32 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2022-05-16 | 60609.91 |
| 2022-05-13 | 60549.06 |
| 2022-05-12 | 60652.51 |
| 2022-05-11 | 60609.91 |
| 2022-05-10 | 60670.76 |
| 2022-05-09 | 60731.62 |
| 2022-05-06 | 60731.62 |
| 2022-05-05 | 61035.88 |
| 2022-05-04 | 60731.62 |
| 2022-05-03 | 60731.62 |
| 2022-05-02 | 60944.60 |
| 2022-04-29 | 60731.62 |
| 2022-04-28 | 60762.04 |
| 2022-04-27 | 60737.70 |
| 2022-04-26 | 60731.62 |
| 2022-04-25 | 60853.32 |
| 2022-04-22 | 60975.03 |
| 2022-04-21 | 60865.49 |
| 2022-04-20 | 60908.09 |
| 2022-04-19 | 60962.86 |
| 2022-04-18 | 60975.03 |
| 2022-04-14 | 60853.32 |
| 2022-04-13 | 60853.32 |
| 2022-04-12 | 60792.47 |
| 2022-04-11 | 60792.47 |
